Lapatinib, a dual inhibitor of EGFR and HER2, has synergistic effects with 5-fluorouracil on esophageal carcinoma

Author:            

Publisher: Spandidos Publications

ISSN: 1021-335X

Source: Oncology Reports, Vol.27, Iss.5, 2012-01, pp. : 1639-1645

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content